This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
171 |
4. Check minimum number of eventsNone |
171 |
5. Include endpointsNone |
171 |
6. Filter based on genotype QC (FinnGen only) |
137 |
Control definitions (FinnGen only)
- Control exclude
- Z21_ADDIT_CODES_LOCAT_DEFECT_INJURY_ILLNE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[AB]
Similar endpoints
↥List of similar endpoints to
Left side
based on the number of shared cases.
Similar with more cases:
- Additional codes for the location of defect, injury or illness
- Diseases of the musculoskeletal system and connective tissue
- Factors influencing health status and contact with health services
- Any operation in hilmo
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 137 | 68 | 69 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 69.33 | 70.81 | 67.88 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 144
- Matched controls
- 1440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ZB0.0
ICD-10 Finland
Left side
+∞
202.1
142
*
WX111
NOMESCO Finland
Local infiltration anesthesia
26.4
75.5
61
39
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
18.5
53.1
49
39
M17.1
ICD-10 Finland
Other primary gonarthrosis
10.4
43.6
100
259
SPAT1212
SPAT
Extensive examination of musculoskeletal system
11.8
40.3
50
62
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
11.1
39.3
52
70
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
9.4
34.3
52
82
Z50.1
ICD-10 Finland
Other physical therapy
11.9
34.2
40
45
M16.1
ICD-10 Finland
Other primary coxarthrosis
7.6
31.8
64
137
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
7.6
30.7
59
120
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
5.8
21.8
53
131
ZB0.1
ICD-10 Finland
Right side
+∞
19.2
18
*
B01AB10
ATC
tinzaparin; parenteral
5.5
18.8
46
113
WX320
NOMESCO Finland
Spinalanesthesy
4.0
14.9
71
284
R4135
NOMESCO Finland
Rehabilitation for hearing problems
16.8
14.7
23
16
Z3231
NOMESCO Finland
Registered nurse
3.9
14.5
73
303
TPH04
NOMESCO Finland
Cathetrisation of vein
3.9
14.0
62
235
U07.2
ICD-10 Finland
COVID-19, virus not identified
4.7
13.6
38
102
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
4.9
13.4
35
89
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
4.0
13.2
50
169
B01AB05
ATC
enoxaparin; parenteral
3.6
12.8
80
374
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
6.1
12.5
24
46
B01AF01
ATC
rivaroxaban; oral
4.0
12.4
45
147
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.8
11.8
47
163
ZXD10
NOMESCO Finland
Scheduled procedure
0.1
10.5
8
410
E66.01
ICD-10 Finland
Obesity due to excess calories
4.7
9.9
25
61
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
3.5
9.1
37
128
M76.4
ICD-10 Finland
Tibial collateral bursitis [Pellegrini-Stieda]
95.4
8.5
9
*
M01AH05
ATC
etoricoxib; oral
3.2
8.5
110
723
N02BE01
ATC
paracetamol; systemic, rectal
26.3
8.3
143
1216
XQ845
NOMESCO Finland
Dermatoscopy
11.8
7.5
13
12
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
3.6
7.4
27
86
WZC30
NOMESCO Finland
Teaching
2.9
7.4
45
196
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.7
7.1
56
278
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
8.2
7.1
15
20
R74
ICPC
Upper respiratory infection acute
0.2
7.1
5
277
WVA20
NOMESCO Finland
Medicine administration
7.5
6.7
15
22
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
9.4
6.7
13
15
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.7
6.7
48
227
WZC00
NOMESCO Finland
Treatment plan or consultation
2.4
6.3
72
421
RTGKO, ,
NOMESCO Finland
+∞
6.3
6
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.5
6.2
58
310
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
3.7
6.1
21
64
M01AX05
ATC
glucosamine; oral
2.5
6.1
49
243
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
50
24
31.38
69.49
1.9
3.5
1.20
1.19
mmol/l
0.27
50
24
50
24
31.38
69.49
1.9
3.5
105.92
106.38
mmol/l
0.20
50
24
50
24
31.38
69.49
1.9
3.5
4.11
3.97
mmol/l
1.08
50
24
82
125
13.91
58.68
1.9
3.1
0.64
0.18
e6/l
0.61
82
120
83
150
11.70
50.99
4.5
4.2
2.19
1.77
mmol/l
0.61
73
126
61
75
13.38
50.25
4.7
4.5
1.36
1.47
%
0.39
61
69
122
424
13.29
39.15
6.9
3.8
0.02
0.00
estimate
0.49
45
140
50
90
7.98
28.99
1.9
2.8
0.76
0.62
%
2.35
50
90
127
570
11.40
27.98
7.4
4.5
0.12
0.00
estimate
1.24
49
140
134
647
16.42
27.06
4.1
3.2
—
—
estimate
—
0
0
130
756
8.40
17.17
7.6
4.3
0.00
0.00
estimate
-0.00
68
173
130
768
8.13
16.51
7.7
4.3
0.00
9.02
estimate
0.50
68
180
129
769
7.50
15.86
7.7
4.4
0.13
0.00
estimate
0.80
61
162
64
231
4.19
15.75
4.4
7.6
105.22
103.65
mmol/l
2.09
64
231
100
606
3.13
9.28
5.2
4.3
32.84
40.47
ng/l
0.41
88
461
0
180
0.00
7.70
0.0
5.1
—
32.09
—
0
111
18
42
4.76
7.46
1.7
1.3
—
—
—
0
0
0
157
0.00
6.65
0.0
8.3
—
—
—
0
0
62
334
2.50
6.58
2.3
1.8
1.35
1.51
mg/l
0.19
55
265
58
308
2.48
6.29
1.6
1.9
364.54
457.33
pmol/l
2.80
50
251
93
634
2.32
5.44
4.6
5.1
36.19
35.06
g/l
1.11
93
595
144
1318
+∞
5.02
26.4
22.6
140.28
139.62
mmol/l
3.31
144
1294
144
1320
+∞
5.02
26.1
22.7
4.07
4.00
mmol/l
3.30
144
1294
14
43
3.50
4.02
4.1
1.4
—
—
—
0
0
144
1338
+∞
4.00
32.5
25.5
81.42
80.76
umol/l
0.08
144
1324
14
343
0.34
3.76
1.6
2.7
—
—
—
0
0
144
1352
+∞
3.44
39.3
28.7
90.88
91.56
fl
1.05
144
1341
144
1352
+∞
3.44
39.9
28.9
133.74
134.66
g/l
0.32
144
1339
144
1352
+∞
3.44
39.4
29.3
33.51
40.27
%
6.64
144
1341
8
15
5.58
3.24
1.4
1.6
—
—
—
0
0
16
62
2.78
3.17
1.7
2.2
1.01
5.25
ug/l
0.47
16
56
6
9
6.90
2.89
1.3
1.3
—
—
—
0
0
73
531
1.76
2.81
3.6
3.5
1853.51
1393.91
ng/l
0.31
68
447
0
67
0.00
2.46
0.0
2.4
—
0.51
—
0
61
32
496
0.54
2.39
2.0
3.4
2.36
2.35
mmol/l
0.22
32
441
0
60
0.00
2.31
0.0
2.3
—
0.00
—
0
54
0
61
0.00
2.30
0.0
1.9
—
—
—
0
0
0
55
0.00
2.12
0.0
1.8
—
—
—
0
0
40
263
1.72
2.10
1.7
1.3
91.80
37.07
iu/ml
—
10
82
7
20
3.62
2.08
1.6
1.4
—
—
—
0
0
16
80
2.13
1.88
1.6
1.4
—
—
—
0
0
5
12
4.27
1.84
1.6
4.8
0.70
1.00
%
—
5
12
0
48
0.00
1.73
0.0
1.3
—
—
—
0
0
0
49
0.00
1.72
0.0
1.3
—
—
—
0
0
77
635
1.46
1.41
2.2
2.2
87.61
97.50
pmol/l
1.57
55
306
16
263
0.56
1.38
1.4
2.0
—
—
—
0
0
0
37
0.00
1.36
0.0
1.8
—
4.46
—
0
27
5
116
0.41
1.32
1.2
1.3
—
—
—
0
0
33
240
1.49
1.12
1.5
1.3
1.80
9.38
u/ml
1.66
25
89
12
199
0.57
1.07
1.2
1.9
—
—
—
0
0
8
143
0.53
1.00
1.1
1.4
—
—
—
0
0
0
29
0.00
0.99
0.0
1.7
—
—
—
0
0
25
177
1.50
0.97
5.4
3.7
—
—
—
0
0
12
191
0.59
0.92
1.2
2.0
—
—
—
0
0
6
30
2.04
0.88
1.7
1.4
—
—
—
0
0
0
24
0.00
0.80
0.0
1.4
—
—
—
0
0
0
24
0.00
0.80
0.0
1.4
—
—
—
0
0
6
107
0.54
0.76
7.0
3.2
175.67
242.49
ng/l
—
6
98
9
57
1.62
0.72
1.2
1.3
—
—
—
0
0
23
296
0.73
0.64
1.1
1.3
0.87
1.27
u/ml
0.36
13
79
0
20
0.00
0.61
0.0
2.4
—
—
—
0
0
0
22
0.00
0.60
0.0
2.3
—
19.60
—
0
10
0
23
0.00
0.59
0.0
1.3
—
—
—
0
0
9
61
1.51
0.55
1.0
1.0
—
—
—
0
0
8
118
0.66
0.48
2.1
1.8
1.45
1.72
%
—
8
101
51
452
1.20
0.43
4.1
4.4
0.00
0.00
estimate
-0.00
40
164
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
2.4
—
—
—
0
0
0
16
0.00
0.41
0.0
2.4
—
—
—
0
0
0
16
0.00
0.41
0.0
2.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
592.18
—
0
11
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
33.65
—
0
11
0
16
0.00
0.41
0.0
2.4
—
—
—
0
0
0
17
0.00
0.41
0.0
2.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
2.4
—
—
—
0
0
49
442
1.16
0.33
1.6
1.7
19.05
22.09
nmol/l
0.65
44
357
62
668
0.87
0.30
1.8
2.6
—
—
—
0
0
19
161
1.21
0.25
1.6
1.3
—
—
—
0
0
5
38
1.33
0.23
1.0
1.8
—
—
—
0
0
18
209
0.84
0.23
7.1
6.6
1.07
1.03
mmol/l
0.26
18
195
16
135
1.21
0.22
2.2
2.3
328.00
383.81
nmol/l
0.58
16
123
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
113.46
—
0
10
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
1.09
—
0
8
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
16
144
1.13
0.11
1.8
2.9
66.63
66.18
g/l
0.07
16
138
5
44
1.14
0.10
1.0
1.7
—
—
—
0
0
5
48
1.04
0.09
1.4
1.3
—
—
—
0
0
6
58
1.04
0.08
1.2
4.2
1.43
2.89
ratio
—
6
27
15
164
0.90
0.08
3.1
3.3
15.33
7.23
umol/l
0.67
15
151
9
103
0.87
0.06
2.1
1.6
—
—
—
0
0
12
123
0.97
0.00
3.1
4.1
99.00
82.38
ng/l
—
6
106
47
473
0.99
0.00
2.4
2.2
238.66
204.50
u/l
0.24
47
445
24
242
0.99
0.00
3.9
1.9
27.61
28.94
s
1.13
24
235
20
202
0.99
0.00
4.3
5.7
205.40
252.75
u/l
3.13
20
195
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
68.07
—
0
7
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
11.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
61
0.98
-0.00
1.2
4.6
41.73
29.89
mg/l
—
6
53
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
61
0.98
-0.00
1.2
4.6
62.38
44.10
mg/l
—
6
53
0
8
0.00
-0.00
0.0
1.6
—
30.61
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
41.34
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_LEFT_SIDE – Left side
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).